Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Statistics in Medicine
|
March 16, 2013
Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions
Sheng Luo, Junsheng Ma, Karl D Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 2, 2018
Adverse event reporting in clinical trials in Parkinson's Disease: Time for change
C Warren Olanow, Christopher Kenney, Stephen Bandak, et al.
Neurology Open Access
|
April 15, 2026
Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical Data
Charles S Venuto, Konnor Herbst, Lana Chahine, et al.
JAMA Neurology
|
October 17, 2014
Treating idiopathic intracranial hypertension--reply
Michael Wall, Michael P McDermott, Karl D Kieburtz, et al.
The International Journal of Neuroscience
|
June 28, 2016
Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations
Neil B Hampson, Karl D Kieburtz, Peter A LeWitt, et al.
Neurology. Clinical Practice
|
June 24, 2022
Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease
Andrew McGarry, Peggy Auinger, Karl D Kieburtz, et al.
Clinical Neuropharmacology
|
January 23, 2023
Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
Peter LeWitt, Grace S Liang, C Warren Olanow, et al.
Annals of Clinical and Translational Neurology
|
July 8, 2016
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
Tanya Simuni, Jeffrey D Long, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology
|
July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
Robert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
JAMA Neurology
|
April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline
Michael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Statistics in Medicine
|
March 16, 2013
Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions
Sheng Luo, Junsheng Ma, Karl D Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 2, 2018
Adverse event reporting in clinical trials in Parkinson's Disease: Time for change
C Warren Olanow, Christopher Kenney, Stephen Bandak, et al.
Neurology Open Access
|
April 15, 2026
Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical Data
Charles S Venuto, Konnor Herbst, Lana Chahine, et al.
JAMA Neurology
|
October 17, 2014
Treating idiopathic intracranial hypertension--reply
Michael Wall, Michael P McDermott, Karl D Kieburtz, et al.
The International Journal of Neuroscience
|
June 28, 2016
Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations
Neil B Hampson, Karl D Kieburtz, Peter A LeWitt, et al.
Neurology. Clinical Practice
|
June 24, 2022
Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease
Andrew McGarry, Peggy Auinger, Karl D Kieburtz, et al.
Clinical Neuropharmacology
|
January 23, 2023
Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
Peter LeWitt, Grace S Liang, C Warren Olanow, et al.
Annals of Clinical and Translational Neurology
|
July 8, 2016
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
Tanya Simuni, Jeffrey D Long, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology
|
July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
Robert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
JAMA Neurology
|
April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline
Michael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
Page
of 2